Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000206267 | SCV000261624 | likely benign | Brugada syndrome | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001722133 | SCV000514477 | likely benign | not provided | 2020-09-21 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25053638, 26733327, 25691538, 25691686, 23115331, 25250524, 28074886) |
Ambry Genetics | RCV002336569 | SCV002636044 | likely benign | Cardiovascular phenotype | 2019-02-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001722133 | SCV004154205 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | SCN10A: BS1 |
Prevention |
RCV004530238 | SCV004742246 | likely benign | SCN10A-related disorder | 2020-05-05 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV001795337 | SCV001923206 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV001722133 | SCV001963043 | likely benign | not provided | no assertion criteria provided | clinical testing |